A deep-learning radiomics based lymph node metastasis predictive model for pancreatic cancer: A diagnostic study.

Researchers

Journal

Modalities

Models

Abstract

Preoperative lymph node (LN) status is essential in formulating the treatment strategy among pancreatic cancer (PC) patients. However, it is still challenging to evaluate the preoperative LN status precisely now.A multivariate model was established based on the multi-view-guided two-stream convolution network (MTCN) radiomics algorithms, which focused on primary tumor and peri-tumor features. Regarding discriminative ability, survival fitting, and model accuracy, different models were compared.363 PC patients were divided in to Train and Test cohorts by 7:3. The modified MTCN (MTCN+) model was established based on age, CA125, MTCN scores, and radiologist judgement. The MTCN+ model outperformed the MTCN model and the Artificial model in discriminative ability and model accuracy. (Train cohort area under curve [AUC]: 0.823 vs. 0.793 vs. 0.592; Train cohort accuracy [ACC]: 76.1% vs. 74.4% vs. 56.7%; Test cohort AUC: 0.815 vs. 0.749 vs. 0.640; Test cohort ACC: 76.1% vs. 70.6% vs. 63.3%; External validation AUC: 0.854 vs. 0.792 vs. 0.542; External validation ACC: 71.4% vs. 67.9% vs. 53.5%) The survivorship curves fitted well between actual LN status and predicted LN status regarding disease free survival (DFS) and overall survival (OS). Nevertheless, the MTCN+ model performed poorly in assessing the lymph node metastatic burden among LN positive population. Notably, among the patients with small primary tumors, the MTCN+ model performed steadily as well. (AUC: 0.823, ACC: 79.5%).A novel MTCN+ preoperative LN status predictive model was established and outperformed the artificial judgement and deep-learning radiomics judgement. Around 40% misdiagnosed patients judged by radiologists could be corrected. And the model could help precisely predict the survival prognosis.Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc.